Kinesin

Potomac Blows past $1.2 billion, Launches on Two New Distribution Channels and Sets Stage for the Next Chapter

Retrieved on: 
Tuesday, September 19, 2023
Consulting, Asset Management, Professional Services, Finance, Business development, Kinesin, Marketing, CUNA Mutual Group, Mondo, AUM, Investment, Interactive Brokers, Asset, Growth, Digital, Region, Nitrogen, News, Cryptocurrency, Financial adviser

“As much as we have accomplished in the past three years, we’re just getting started,” said Jeff Goodnow, Chief Growth Officer of Potomac.

Key Points: 
  • “As much as we have accomplished in the past three years, we’re just getting started,” said Jeff Goodnow, Chief Growth Officer of Potomac.
  • Potomac continues to expand nationally, and work with companies to add risk-managed solutions.
  • This business is still about building relationships, and boots on the ground is how you accomplish it,” said Manish Khatta, CEO of Potomac.
  • Prior to joining Potomac, Flig was a Demand Generation Specialist at Mondo and a Business Development Representative at Nitrogen.

Preclinical Data on Volastra Therapeutics’ Two Novel and Differentiated KIF18A Inhibitors Presented at AACR 2023

Retrieved on: 
Sunday, April 16, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, CIN, AACR, FRCP, Chromosome, Neoplasm, Cell, Patient, Kinesin, Growth, Therapy, PARP, Pharmaceutical industry, Volastra

Volastra Therapeutics , a clinical-stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), today released preclinical data from the company’s portfolio of KIF18A inhibitors at the 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando.

Key Points: 
  • Volastra Therapeutics , a clinical-stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), today released preclinical data from the company’s portfolio of KIF18A inhibitors at the 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando.
  • Volastra’s KIF18A portfolio consists of two clinical-stage highly differentiated, novel, first-in-class KIF18A inhibitors: recently in-licensed sovilnesib (formally AMG650) and internally-developed VLS-1488.
  • “We are proud to have side-by-side posters on our two groundbreaking KIF18A inhibitors at AACR,” said Charles Hugh-Jones, M.D., FRCP, Chief Executive Officer at Volastra.
  • Findings for one of Volastra’s internally-developed KIF18A inhibitors are shown in a second poster, entitled “Targeting chromosomally unstable tumors with a selective KIF18A inhibitor” (#517).

Molecular robots work cooperatively in swarms

Retrieved on: 
Wednesday, April 20, 2022
Veni, vidi, vici, NEDO, DNA, Robotics, Nagoya University, Scientific method, Research, New Energy and Industrial Technology Development Organization, Kansai University, Collection, Transport, Future, New energy, Associate, Kinesin, Columbia University, Ministry, Hokkaido University, Efficiency, Development, Science and technology, List, Environment, MEXT, Workload, Faculty, Culture, McMaster Faculty of Science, Microtubule, Kyushu University, Assistant, Medical device, Beekeeping, 3D printing, Sport, Technology, Science, Education

Swarm robotics is a new discipline, inspired by the cooperative behavior of living organisms, that focuses on the fabrication of robots and their utilization in swarms to accomplish complex tasks.

Key Points: 
  • Swarm robotics is a new discipline, inspired by the cooperative behavior of living organisms, that focuses on the fabrication of robots and their utilization in swarms to accomplish complex tasks.
  • Macro-scale swarm robots have been developed and employed for a variety of applications, such as transporting and accumulating cargo, forming shapes, and building complex structures.
  • However, the DNA and azobenzene used in the molecular machines and the cargo were different, so swarming could be controlled independently of cargo-loading.
  • "In the near future, we expect to see microrobot swarms used in drug delivery, contaminant collection, molecular power generation devices, and micro-detection devices," says Akira Kakugo.

Molecular robots work cooperatively in swarms

Retrieved on: 
Wednesday, April 20, 2022
Veni, vidi, vici, NEDO, DNA, Robotics, Nagoya University, Scientific method, Research, New Energy and Industrial Technology Development Organization, Kansai University, Collection, Transport, Future, New energy, Associate, Kinesin, Columbia University, Ministry, Hokkaido University, Efficiency, Development, Science and technology, List, Environment, MEXT, Workload, Faculty, Culture, McMaster Faculty of Science, Microtubule, Kyushu University, Assistant, Medical device, Beekeeping, 3D printing, Sport, Technology, Science, Education

Swarm robotics is a new discipline, inspired by the cooperative behavior of living organisms, that focuses on the fabrication of robots and their utilization in swarms to accomplish complex tasks.

Key Points: 
  • Swarm robotics is a new discipline, inspired by the cooperative behavior of living organisms, that focuses on the fabrication of robots and their utilization in swarms to accomplish complex tasks.
  • Macro-scale swarm robots have been developed and employed for a variety of applications, such as transporting and accumulating cargo, forming shapes, and building complex structures.
  • However, the DNA and azobenzene used in the molecular machines and the cargo were different, so swarming could be controlled independently of cargo-loading.
  • "In the near future, we expect to see microrobot swarms used in drug delivery, contaminant collection, molecular power generation devices, and micro-detection devices," says Akira Kakugo.